- Today's Hot Chat Topics
- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Skyepharma Share News (SKP)
Share News for Skyepharma (SKP)
| Share Price: 48.25 | Bid: 40.00 | Ask: 84.00 | Change: -0.875 (-1.78%) |  | ||||||
| ||||||||||
Skyepharma says bond proposals, placing, open offer seen finalised on Sept. 25
Tue, 23rd Sep 2008 15:55
LONDON (Thomson Financial) - Specialist British drug delivery company Skyepharma Plc. said it
It added it expects the consolidated new shares to be issued pursuant to the placing and open offer to be admitted to the Official List and to commence trading on the London Stock Exchange on Sept. 26 and the bond proposals to be implemented on or around Oct. 1.
On Sept. 1, SkyePharma had said in a statement it would sell 1.4 billion new shares at 1.5 pence in an underwritten placing and open offer.
It had also stated 70 percent of the holders of its 2024 convertible bond and 100 percent of the holders of its 2025 convertible had agreed to proposed changes to the conversion price and dates for put options on the two convertibles.
TFN.newsdesk@thomson.com
npr/slm
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
LONDON (Thomson Financial) - Specialist British drug delivery company Skyepharma Plc. said it
expects its bond proposals, placing and open offer to be finalised on Sept 25.
It added it expects the consolidated new shares to be issued pursuant to the placing and open offer to be admitted to the Official List and to commence trading on the London Stock Exchange on Sept. 26 and the bond proposals to be implemented on or around Oct. 1.
On Sept. 1, SkyePharma had said in a statement it would sell 1.4 billion new shares at 1.5 pence in an underwritten placing and open offer.
It had also stated 70 percent of the holders of its 2024 convertible bond and 100 percent of the holders of its 2025 convertible had agreed to proposed changes to the conversion price and dates for put options on the two convertibles.
TFN.newsdesk@thomson.com
npr/slm
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
BRIEF-Skyepharma - Revenues show strong growth
LONDON, Oct 27 (Reuters) - SkyePharma PLC: * Revenues since July 1, continue to show significant growth compared with the 2007 run r[27 Oct '08]
BRIEF-SkyePharma successfully completes Flutiform U.S. trials
LONDON, Oct 23 (Reuters) - SkyePharma PLC: * Successful completion of Flutiform U.S. clinical trial programme * Final U.S. Phase III e[23 Oct '08]
Skyepharma says bond proposals, placing, open offer seen finalised on Sept. 25
LONDON (Thomson Financial) - Specialist British drug delivery company Skyepharma Plc. said it expects its bond proposals, placing and open offer[23 Sep '08]
STOCKS NEWS EUROPE-UK small cap index stay flat
Sept 4 (Reuters) - STOCKS NEWS Reuters Results diary Stocks on the move [HOT-RTRS] Real-time Equity News [E] [WEU/EQUITY] 07:48GM[4 Sep '08]
CORRECTED-STOCKS NEWS EUROPE-UK small caps fall 0.2%
Sept 4 (Reuters) - (Corrects comparison to show pan-European small caps underperformed the large caps) STOCKS NEWS Reuters Results dia[4 Sep '08]
UPDATE 1-SkyePharma sets new terms for convertibles
LONDON, Sept 1 (Reuters) - Specialist British drug delivery company SkyePharma Plc[1 Sep '08]
BRIEF-SkyePharma in 18.4 mln stg placing and open offer
LONDON, Sept 1 (Reuters) - SkyePharma Plc[1 Sep '08]
SkyePharma bond renegotiation deal seen 'this week'
LONDON, Sept 1 (Reuters) - Specialist drug delivery company SkyePharma Plc is set to announce a renegotiation of its convertible bonds this week[1 Sep '08]
